Abstract
Neurofibromatosis type 2 (NF2) is a monogenic dominantly inherited disease predisposing carriers to develop nervous system tumours. To identify the genetic defect, the region between two flanking polymorphic markers on chromosome 22 was cloned and several genes identified. One is the site of germ-line mutations in NF2 patients and of somatic mutations in NF2-related tumours. Its deduced product has homology with proteins at the plasma membrane and cytoskeleton Interface, a previously unknown site of action of tumour suppressor genes in humans.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tos, M. & Thomsen, J. J. Lar. Otol. 98, 685–692 (1984).
Martuza, R. L. & Eldridge, R. N. Engl. J. Med. 318, 684–688 (1988).
Barker, D. et al. Science 236, 1100–1102 (1987).
Seizinger, B. R. et al. Cell 49, 589–594 (1987).
Rouleau, G. A. et al. Nature 329, 246–248 (1987).
Narod, S. A. et al. Am J. hum. Genet. 51, 486–496 (1992).
Seizinger, B. R., Martuza, R. L. & Gusella, J. F. Nature 332, 644–647 (1986).
Couturier, J. et al. Cancer Genet. Cytogenet. 45, 55–62 (1990).
Seizinger, B. R., de la Monte, S., Atkins, L., Gusella, J. F. & Martuza, R. L. Proc. natn. Acad. Sci. U.S.A. 84, 5419–5423 (1987).
Dumanski, J. P., Carlbom, E., Collins, V. P. & Nordenskjöld, M. Proc. natn. Acad. Sci. U.S.A. 84, 9275–9279 (1987).
Dumanski, J. P., Rouleau, G. A., Nordenskjöld, M. & Collins, V. P. Cancer Res. 50, 5863–5867 (1990).
Ruttledge, M. H. et al. Neurology (in the press).
Delattre, O. et al. Genomics 9, 721–727 (1991).
Dumanski, J. P. et al. Hum. Genet. 84, 219–222 (1990).
Zucman, J. et al. Genes Chrom. Cancer 5, 271–277 (1992).
Lindsay, S. & Bird, A. P. Nature 327, 336–338 (1987).
Delattre, O. et al. Nature 359, 162–165 (1992).
Mattei, M. G. et al. Hum. Genet. 80, 293–295 (1988).
Lees, J., Shneidman, P. S., Skuntz, S. F., Carden, M. J. & Lazzarini, R. A. EMBO J. 7, 1947–1955 (1988).
Kozac, M. Nucleic Acids Res. 16, 8125–8130 (1966).
Altshul, S. F. et al. J. molec. Biol. 215, 403–410 (1990).
Lankes, W. T. & Furthmayr H. Proc. natn. Acad. Sci. U.S.A. 88, 8297–8301 (1991).
Gould, K. L., Bretscher, A., Esch, F. S. & Hunter, T. EMBO J. 8, 4133–4142 (1989).
Turunen, O. et al. J. biol. Chem. 264, 16727–16732 (1989).
Yang, Q. & Tonks, N. K. Proc. natn. Acad. Sci. U.S.A. 88, 5949–5953 (1991).
Conboy, J., Kan, Y. W., Shohet, S. B. & Mohandas, N. Proc. natn. Acad. Sci. U.S.A. 83, 9512–9516 (1986).
Kahre, O., Ilves, H. & Speek, M. Molec. cell. Biol. 12, 4242–4248 (1992).
Myer, R. M., Fisher, S. G., Lerman, L. S. & Maniatis T. Nucleic Acids Res. 13, 3131–3145 (1985).
Rees, D. J. G., Ades, S. E., Singer, S. J. & Hynes, R. O. Nature 347, 685–689 (1990).
Jenkins, R. B. et al. Cancer Genet. Cytogenet. 39, 253–279 (1989).
Tanaka, N. et al. Genes Chrom. Cancer 5, 399–403 (1992).
Okamoto, M. et al. Nature 331, 273–277 (1988).
Chen, L. C., Kurisu, W., Ngo, J., Moore, D. & Smith, H. S. Cancer Res. 32, 300 (1991).
Evans, D. G. R. et al. J. med. Genet. 29, 841–846 (1992).
Lerman, L. S. & Silverstein, K. Meth. Enzym. 155, 482–501 (1987).
NIH Consens Dev Conf Consens Statement 9(4), (Dec 11–13 1991).
van Leewen, C. et al. Nucleic Acids Res. 19, 5805 (1991).
Spirio, L., Joslyn, G., Nelson, L., Leppert, M. & White, R. Nucleic. Acids Res. 19, 6348 (1991).
Fontaine, B. et al. Genomics 10, 280–283 (1992).
Bijisma, E. et al. Genes Chrom. Cancer, 5, 201–205 (1992).
Desmaze, C., Zucman, J., Delattre, O., Thomas, G. & Aurias, A. Genes Chrom. Cancer 5, 30–34 (1992).
Maniatis, T., Fritsh, E. F. & Sambrook, J. Molecular Cloning, A Laboratory Manual (Cold Spring Harbor Laboratory Press, New York, 1989).
Henikoff, S. GENE 28, 357 (1984).
Olschwang, S., Laurent-Puig, P., Groden, J., White, R. & Thomas G. Am. J. hum Genet 52, 273–279 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rouleau, G., Merel, P., Lutchman, M. et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363, 515–521 (1993). https://doi.org/10.1038/363515a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/363515a0
This article is cited by
-
Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective
Journal of Neuro-Oncology (2024)
-
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions
Oncology and Therapy (2024)
-
Mutational signature of extracranial meningioma metastases and their respective primary tumors
Acta Neuropathologica Communications (2023)
-
A novel BRAF::PTPRN2 fusion in meningioma: a case report
Acta Neuropathologica Communications (2023)
-
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Cancer Cell International (2023)